1.
Norum J, Olsen JA, Wist EA, Lønning PE. Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis. AO [Internet]. 2007 Jan. 1 [cited 2026 May 20];46(2):153-64. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/26229